Twist Bioscience Corp (TWST)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $6.96B
Last updated: Nov 17, 2026 at 4:43 PM ET
Twist Bioscience Corp (TWST) Stock Chart
Twist Bioscience (TWST) has a latest price of $112.00 on Nov 17, 2026, 49.0% below its 52-week high of $219.71. Its price rose 316.8% over the past 12 months. The month-end price rose 991.3% since Oct 2018, a compound annual rate of 34.8%.
Price Chart
From Oct 2018 to Oct 2026, its highest month-end close was $193.24 in Sep 2026 and its lowest $12.48 in Apr 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TWST with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TWST.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 21.3%, and over 6 months it rose 126.3%. The month-end price rose 869.4% over the 3 years through Oct 2026, a compound annual rate of 113.2%.
| Period | Change |
|---|---|
| 1 month | -19.9% |
| 3 months | -21.3% |
| 6 months | +126.3% |
| 12 months | +316.8% |
| 12 months, with dividends | +316.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +869.4% | +113.2% |
| 5 years | +28.6% | +5.2% |
| Since Oct 2018 | +991.3% | +34.8% |
Price by Year
Its best calendar year was 2020, when the price rose 572.8%, and its weakest was 2022, when it fell 69.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $152.78 | +381.7% |
| 2025 | $31.72 | -31.7% |
| 2024 | $46.47 | +26.1% |
| 2023 | $36.86 | +54.8% |
| 2022 | $23.81 | -69.2% |
| 2021 | $77.39 | -45.2% |
| 2020 | $141.29 | +572.8% |
| 2019 | $21.00 | -9.1% |
Trading Range
The price is 25.1% below its 50-day average of $149.51 and 19.3% above its 200-day average of $93.88.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $112.00 | |
| 52-week high | $219.71 | -49.0% |
| 52-week low | $25.23 | +343.9% |
| 50-day average | $149.51 | -25.1% |
| 200-day average | $93.88 | +19.3% |
Price Risk
Over 3 years, its largest fall from a peak was 59.0%.
| Measure | Value |
|---|---|
| 1-year beta | 2.87 |
| Largest fall, 1 year | -48.8% |
| Largest fall, 3 years | -59.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TWST
What is TWST's 1-year price change?
Twist Bioscience's price rose 316.8% over the past 12 months. With dividends included, the 12-month total return was 316.8%.
What is TWST's 5-year price change?
Twist Bioscience's month-end price rose 28.6% over the 5 years through Oct 2026, a compound annual rate of 5.2%. These figures leave out dividends.
What is TWST's 52-week high and low?
Twist Bioscience's 52-week high is $219.71 and its 52-week low is $25.23. Its latest price of $112.00 on Nov 17, 2026 is 49.0% below the high.
What is TWST's beta?
Twist Bioscience's 1-year beta against the S&P 500 is 2.87, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 48.8%.
Is the TWST chart free?
Yes. Advanced Charting for TWST is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TWST pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts